Quantcast

Latest Anticonvulsant Stories

2014-10-22 08:30:29

Seattle and Spokane Host Conferences SEATTLE, Oct. 22, 2014 /PRNewswire-USNewswire/ -- Dr. Jeffrey Bucchalter, Director of the Comprehensive Children's Epilepsy Center at Alberta Children's Hospital. Dr. Bucchalter will speak on Sudden Unexpected Death in Epilepsy (SUDEP) - A Conversation Based on Risk and Empathy. SUDEP is the leading cause of premature death among people with epilepsy, and an epilepsy topic gaining more attention in research and patient-provider relationships....

2014-10-17 23:06:17

Although high market concentration among anticonvulsant manufacturers has limited the number of suppliers available to buyers, rising competition from generic anticonvulsants and pressure to contain costs has helped buyers maintain negotiation power. For these reasons and to help procurement professionals make better buying decisions faster, business intelligence firm IBISWorld has updated a report on the procurement of Anticonvulsants in its growing collection of procurement category...

2014-10-14 20:23:21

Seattle and Spokane Host Conferences SEATTLE, Oct. 14, 2014 /PRNewswire-USNewswire/ -- The Epilepsy Foundation Northwest announces two regional conferences in November celebrating National November Epilepsy Awareness Month. The conferences will be held in Seattle, WA and Spokane, WA, and are free and open to the public. The conference in Seattle will be on Saturday, November 8 at the Wright Auditorium at Seattle Children's Hospital from 8:30 am to 4:30 pm. Keynote speaker, Dr....

2014-09-03 08:32:44

TORONTO, Sept. 3, 2014 /CNW/ - Donovan Charlong was a baseball loving boy, with a mischievous smile and energy enough to light up his hometown of Paris, Ontario. Just eighteen days before his 12(th) birthday, on June 10 of this year, he died. A four-year battle with Febrile Infection Related Epilepsy Syndrome (F.I.R.E.S.) had weakened him, so badly he could no longer fight on. FIRES is an extreme and rare form of epilepsy which affects previously healthy children. Donovan's...

2014-07-22 08:30:55

LOS ANGELES, July 22, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) Therapy for the treatment of neurological and neuropsychiatric disorders, today announced that enrollment has begun in a pediatric open label study of external trigeminal nerve stimulation (eTNS) as adjunctive therapy for the treatment of Lennox-Gastaut Syndrome (LGS). The trial is being conducted at...

2014-07-16 20:23:07

LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability https://www.reportbuyer.com/product/2052296/Epilepsy-Therapeutics-in-Asia-Pacific-Markets-to-2019---Treatment-Options-Enhanced-As-Novel-Next-Generation-AEDs-Show-Improved-Safety-and-Tolerability.html Epilepsy Therapeutics in Asia Pacific...

2014-07-15 08:28:37

WAYNE, Pa. and PORTO, Portugal, July 15, 2014 /PRNewswire/ -- BIAL, a research based international pharmaceutical company, and moksha8, a leading specialty pharmaceutical company in Latin America, announced today an exclusive license for the commercialization of eslicarbazepine acetate (Zebinix® / (Exalief®) in Brazil and Mexico for the treatment of epilepsy. Epilepsy is one of the most common neurological diseases, affecting 70 million worldwide and up to 5 million people in Latin America...

2014-07-08 08:29:45

European Clinical Data and Mechanism of Action Results Presented LOS ANGELES, July 8, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) System for the treatment of neurological and neuropsychiatric disorders, today announced top-line summaries of presentations made last week at the 11th European Congress on Epileptology in Stockholm, Sweden, related to the use of external...

2014-06-25 12:29:20

SALT LAKE CITY and TORONTO, June 25, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules announces today that it has received a research grant from the Ontario Brain Institute for its Lorazepam Spray development. The grant was issued for the purpose to study the administration of a...

2014-06-17 12:28:18

SALT LAKE CITY and TORONTO, June 17, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules expands on its pharmaceutical research and development plans. EastGate has entered into a working collaboration with Dr. Peter Carlen, leading neurologist at Toronto Western Hospital,...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.